Isia Biotech Overview
- Year Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
Series B
- Investors
-
3
Isia Biotech General Information
Description
Developer and producer of in vitro diagnostic (IVD) medical technology designed to detect and diagnose diseased based on an immune reaction. The company's technology applies its proprietary quantum dot technology through an immune reaction to test cardiovascular disease, inflammation, bone metabolism, gastric function, renal function, cancer, and other autoimmune diseases, enabling doctors to improve their ability to detect, diagnose and treat diseases.
Contact Information
Website
www.isiabio.comCorporate Office
- No.388, Jingdongfang Avenue
- Beibei District
- Chongqing, 400714
- China
Corporate Office
- No.388, Jingdongfang Avenue
- Beibei District
- Chongqing, 400714
- China
Isia Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 22-Jul-2022 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 25-Dec-2020 | Completed | Generating Revenue |
Isia Biotech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chongqing Boyi Equity Investment Fund Management | Growth/Expansion | Minority | ||
| YuanBio Venture Capital | Venture Capital | Minority | ||
| Huaying Investment | Venture Capital | Minority |
Isia Biotech FAQs
-
When was Isia Biotech founded?
Isia Biotech was founded in 2012.
-
Where is Isia Biotech headquartered?
Isia Biotech is headquartered in Chongqing, China.
-
What industry is Isia Biotech in?
Isia Biotech’s primary industry is Diagnostic Equipment.
-
Is Isia Biotech a private or public company?
Isia Biotech is a Private company.
-
What is the current valuation of Isia Biotech?
The current valuation of Isia Biotech is .
-
What is Isia Biotech’s current revenue?
The current revenue for Isia Biotech is .
-
Who are Isia Biotech’s investors?
Chongqing Boyi Equity Investment Fund Management, YuanBio Venture Capital, and Huaying Investment have invested in Isia Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process